On 2025-04-08, Nurix Therapeutics, Inc. (NRIX) announced earnings per share of $-0.67 for the fiscal quarter ending 2025-02-28, beating the average analyst estimate of $-0.72.
The next expected annoucement date for quarterly earnings is 2025-07-10, with an average estimated earnings per share of $-0.73 for the fiscal quarter ending 2025-05-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-04-08 | 2025-02-28 | $-0.72 | $-0.67 |
| 2025-01-28 | 2024-11-30 | $-0.67 | $-0.75 |
| 2024-10-11 | 2024-08-31 | $-0.67 | $-0.67 |
| 2024-07-11 | 2024-05-31 | $-0.66 | $-0.71 |
| 2024-04-10 | 2024-02-29 | $-0.80 | $-0.76 |
| 2024-02-15 | 2023-11-30 | $-0.51 | $-0.77 |
| 2023-10-12 | 2023-08-31 | $-0.69 | $-0.68 |
| 2023-07-13 | 2023-05-31 | $-0.63 | $-0.45 |
| 2023-04-13 | 2023-02-28 | $-0.90 | $-0.75 |
| 2023-02-09 | 2022-11-30 | $-0.68 | $-0.87 |
| 2022-10-06 | 2022-08-31 | $-0.99 | $-0.90 |
| 2022-07-07 | 2022-05-31 | $-1.00 | $-1.01 |
| 2022-04-07 | 2022-02-28 | $-0.89 | $-0.95 |
| 2022-01-27 | 2021-11-30 | $-0.67 | $-0.85 |
| 2021-10-14 | 2021-08-31 | $-0.66 | $-0.65 |
| 2021-07-13 | 2021-05-31 | $-0.56 | $-0.60 |
| 2021-04-13 | 2021-02-28 | $-0.43 | $-0.63 |
| 2021-02-16 | 2020-11-30 | $-0.54 | $-0.51 |
| 2020-10-14 | 2020-08-31 | $-0.40 | $-0.59 |